Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: A phase II study

1. Gonzalez, E.E.
2. Villanueva, N.
3. Fra, J.
4. Berros, J.P.
5. Jimenez, P.
6. Luque, M.
7. Muñiz, I.
8. Blay, P.
9. Fernandez, Y.
10. Vieitez, J.M.
11. Muriel, C.
12. Sanmamed, M.
13. Coto, P.P.
14. Izquierdo, M.
15. Estrada, E.
16. Lacave, A.J.